Form 4: Elanco Director Garcia Acquires Shares

Director Art A. Garcia of Elanco Animal Health Inc. acquired shares through equity awards, increasing his beneficial ownership.

Summary

• Art A. Garcia, a Director at Elanco Animal Health Inc., acquired shares through two separate transactions on May 21, 2026.
• The first transaction involved the acquisition of 4,678 shares of Common Stock as a pro-rated annual equity award in the form of deferred stock units.
• The second transaction involved the acquisition of 12,196 shares of Common Stock as an annual equity award in the form of restricted stock units.
• Following these transactions, Mr. Garcia's beneficial ownership of Elanco Animal Health Inc. common stock increased.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine equity awards to a director and does not indicate significant changes in ownership or company performance.

Positives

• Director Art A. Garcia received equity awards, indicating continued alignment of management and board interests with shareholders.
• The acquisition of both deferred stock units and restricted stock units suggests a comprehensive approach to long-term incentive compensation for directors.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the animal health industry to incentivize long-term performance and align executive interests with shareholders. This type of disclosure is standard for Section 16 reporting.

Stakeholder Impact

• Shareholders: The equity awards reinforce the alignment of director interests with shareholder value, which is generally viewed positively.

Key Dates

Keywords

Elanco Animal Health, Form 4, SEC Filing, Insider Trading, Equity Awards, Director Compensation, Securities Ownership